Universal CAR-γδT Cell Injection in the AML Patients
Clinical trial NCT05388305 · UNKNOWN
Trial details
- NCT number
- NCT05388305
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2023-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.